Detalhe da pesquisa
1.
Metabolic Dysfunction-Associated Fibrosis Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction.
Gastroenterology
; 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513745
2.
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy.
Gastroenterology
; 166(1): 168-177.e8, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769952
3.
Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe.
J Hepatol
; 80(2): 243-250, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37898348
4.
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38483300
5.
Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study.
Hepatology
; 77(2): 585-593, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35753042
6.
Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 21(12): 3089-3096.e1, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37004973
7.
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 21(6): 1513-1522.e4, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35863683
8.
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study).
Gastroenterology
; 162(3): 757-771.e4, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34762906
9.
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 118(9): 1601-1608, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719174
10.
Liver stiffness is associated with excess mortality in the general population driven by heart failure: The Rotterdam Study.
Liver Int
; 43(5): 1000-1007, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36744819
11.
The Yield of Routine Post-Operative Doppler Ultrasound to Detect Early Post-Liver Transplantation Vascular Complications.
Transpl Int
; 36: 11611, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38093807
12.
Substantial impact of the COVID-19 pandemic on the reported number of diagnosed chronic hepatitis C virus infections in the Netherlands, 2019-2021.
BMC Public Health
; 23(1): 1244, 2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37370036
13.
Levels of Antibodies to Hepatitis B Core Antigen Are Associated With Liver Inflammation and Response to Peginterferon in Patients With Chronic Hepatitis B.
J Infect Dis
; 227(1): 113-122, 2022 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35599306
14.
Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study.
J Infect Dis
; 225(11): 1967-1973, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32318704
15.
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels.
J Hepatol
; 76(5): 1042-1050, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35092743
16.
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE).
Clin Gastroenterol Hepatol
; 20(4): e784-e793, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33309804
17.
Ultra-Long-term Follow-up of Interferon Alfa Treatment for HBeAg-Positive Chronic Hepatitis B Virus Infection.
Clin Gastroenterol Hepatol
; 19(9): 1933-1940.e1, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32890755
18.
Mean HBsAg decline at week 24 of PEG-IFN-based treatment predicts subsequent rate of HBsAg clearance - suggesting a valuable endpoint for early development HBV trials.
J Viral Hepat
; 28(11): 1563-1569, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34435408
19.
Effects of on-treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infection.
J Viral Hepat
; 28(12): 1729-1737, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34514678
20.
Hepatitis B core-related antigen levels predict recurrence-free survival in patients with HBV-associated early-stage hepatocellular carcinoma: results from a Dutch long-term follow-up study.
J Viral Hepat
; 28(1): 205-208, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32869922